top of page
Recent Posts
Search

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

  • OPACC
  • Apr 9, 2024
  • 1 min read

Findings from scientists at St. Jude Children’s Research Hospital and The University of Tennessee Health Science Center suggest T-cell therapy could effectively treat fibrolamellar carcinoma.


Recent Posts

See All

Kommentare


Archive
Search By Tags
Rama logo.png
cgcg logo.jpg

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

705-828-7965

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • YouTube Social  Icon
bottom of page